(Q36176856)

12 August 2017

1 reference

title

Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability (English)

1 reference

12 August 2017

0 references

1 reference

David Wheatley

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Journal of Psychopharmacology

12 August 2017

published in

1 reference

12 August 2017

volume

19

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

414-421

1 reference

Sleep as a restorative process and a theory to explain why.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Seasonal variation of the essential oil, valerenic acid and derivatives, and velopotriates in Valeriana officinalis roots and rhizomes, and the selection of plants suitable for phytomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Aromatherapy positively affects mood, EEG patterns of alertness and math computations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Critical evaluation of the effect of valerian extract on sleep structure and sleep quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Hepatitis associated with Kava, a herbal remedy for anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Receptor Bindings Studies withValeriana officinalison the Benzodiazepine Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Quantifying the effects of mild sedatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin - A double-blind placebo-controlled study of four weeks treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Double blind study of a valerian preparation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

The recuperative effects of REM sleep and stage 4 sleep on human performance after complete sleep loss: experiment I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Risks of dependence on benzodiazepine drugs: the importance of patient selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Effects of kawain and dihydromethysticin on field potential changes in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

Stress-induced insomnia treated with kava and valerian: singly and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053309

21 January 2018

Identifiers

DOI

10.1177/0269881105053309

1 reference

12 August 2017

1 reference